Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | CTSS | P25774 | 5/20 | 0.44 |
| ▸ | KDM4A | O75164 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.43 |
| ▸ | CTSL | P07711 | 1/20 | 0.40 |
| ▸ | KCNQ2 | O43526 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CCR3 | P51677 | 1/20 | 0.40 |
| ▸ | CRHBP | P24387 | 2/20 | 0.39 |
| ▸ | CRHR2 | Q13324 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6689715 | 0.90 | CTSS (0.52) | CTSSCTSL | |
| SCHEMBL6694225 | 0.88 | EPHX1 (0.45) | MEN1KMT2ACTSSEPHX1CTSL | |
| SCHEMBL6687363 | 0.88 | EPHX1 (0.45) | MEN1KMT2ACTSSEPHX1CTSL | |
| SCHEMBL6685626 | 0.87 | CTSS (0.47) | MEN1KMT2ACTSSCTSL | |
| SCHEMBL6692653 | 0.83 | CTSS (0.43) | CTSSEPHX1CTSLCCR3 | |
| SCHEMBL6694181 | 0.82 | CTSS (0.51) | CTSSCTSL | |
| SCHEMBL5844425 | 0.80 | CTSS (0.58) | CTSSCTSL | |
| SCHEMBL5844420 | 0.80 | CTSS (0.58) | CTSSCTSL | |
| SCHEMBL6691194 | 0.80 | CTSS (0.41) | CTSSEPHX1CTSLCCR3 | |
| SCHEMBL6688775 | 0.80 | CTSS (0.41) | CTSSEPHX1CTSLCCR3CRHBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004084842-A2 | INHIBITORS OF CATHEPSIN S | IRM LLC (BM) | 2004-10-07 | — | — | WO | disclosed |